FMR LLC sold 6.0% of their position (290.91K shares) of SANA BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $1.89M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 1/10/2025ACC: 0000950170-25-004052
-290.91K
Net shares
Net seller
$1.89M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
290.91K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−100K
Price / share
$6.11
Trade value
$611K
% of position
2.1%
1/8/2025
4.83M→4.73M
Common Stock
Indirect
Shares
−25K
Price / share
$6.50
Trade value
$162.50K
% of position
0.5%
1/8/2025
4.73M→4.71M
Common Stock
Indirect
Shares
−164.91K
Price / share
$6.71
Trade value
$1.11M
% of position
3.5%
1/8/2025
4.71M→4.54M
Common Stock
Indirect
Shares
−1K
Price / share
$7.26
Trade value
$7.26K
% of position
0.0%
1/8/2025
4.54M→4.54M
Total
Net shares
−290.91K
Net value
-$1.89M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/8/2025 | S · Sale | −100K | $6.11 | $611K | 2.1% | 4.83M | 4.73M |
| Common Stock Indirect | 1/8/2025 | S · Sale | −25K | $6.50 | $162.50K | 0.5% | 4.73M | 4.71M |
| Common Stock Indirect | 1/8/2025 | S · Sale | −164.91K | $6.71 | $1.11M | 3.5% | 4.71M | 4.54M |
| Common Stock Indirect | 1/8/2025 | S · Sale | −1K | $7.26 | $7.26K | 0.0% | 4.54M | 4.54M |
| Total | −290.91K | -$1.89M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned61.00
Total
61.00 indirect61.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 61.00 | Indirect |
| Total | 61.00 | 61.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported